• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

供者来源造血干细胞龛移植促进嵌合状态介导的供者特异性免疫耐受。

Donor derived hematopoietic stem cell niche transplantation facilitates mixed chimerism mediated donor specific tolerance.

机构信息

Department of Plastic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.

Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.

出版信息

Front Immunol. 2023 Feb 16;14:1093302. doi: 10.3389/fimmu.2023.1093302. eCollection 2023.

DOI:10.3389/fimmu.2023.1093302
PMID:36875068
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9978155/
Abstract

Compelling experimental evidence confirms that the robustness and longevity of mixed chimerism (MC) relies on the persistence and availability of donor-derived hematopoietic stem cell (HSC) niches in recipients. Based on our prior work in rodent vascularized composite allotransplantation (VCA) models, we hypothesize that the vascularized bone components in VCA bearing donor HSC niches, thus may provide a unique biologic opportunity to facilitate stable MC and transplant tolerance. In this study, by utilizing a series of rodent VCA models we demonstrated that donor HSC niches in the vascularized bone facilitate persistent multilineage hematopoietic chimerism in transplant recipients and promote donor-specific tolerance without harsh myeloablation. In addition, the transplanted donor HSC niches in VCA facilitated the donor HSC niches seeding to the recipient bone marrow compartment and contributed to the maintenance and homeostasis of stable MC. Moreover, this study provided evidences that chimeric thymus plays a role in MC-mediated transplant tolerance through a mechanism of thymic central deletion. Mechanistic insights from our study could lead to the use of vascularized donor bone with pre-engrafted HSC niches as a safe, complementary strategy to induce robust and stable MC-mediated tolerance in VCA or solid organ transplantation recipients.

摘要

强有力的实验证据证实,混合嵌合体(MC)的稳健性和持久性依赖于受者中供体来源造血干细胞(HSC)龛的持续存在和可用性。基于我们在啮齿动物血管化复合组织同种异体移植(VCA)模型中的先前工作,我们假设 VCA 承载供体 HSC 龛的血管化骨成分可能提供了一个独特的生物学机会,以促进稳定的 MC 和移植耐受。在这项研究中,我们利用一系列啮齿动物 VCA 模型证明,血管化骨中的供体 HSC 龛促进了移植受者中持续的多谱系造血嵌合体,并在没有强烈骨髓清除的情况下促进了供体特异性耐受。此外,VCA 中移植的供体 HSC 龛有助于供体 HSC 龛播种到受者骨髓腔室,并有助于稳定 MC 的维持和稳态。此外,这项研究提供的证据表明,嵌合胸腺通过胸腺中央删除机制在 MC 介导的移植耐受中发挥作用。我们研究中的机制见解可能导致使用带有预先植入 HSC 龛的血管化供骨作为一种安全、互补的策略,以在 VCA 或实体器官移植受者中诱导强大和稳定的 MC 介导的耐受。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2851/9978155/02c6797478f0/fimmu-14-1093302-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2851/9978155/92b85211e1ff/fimmu-14-1093302-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2851/9978155/b27381e5e0e8/fimmu-14-1093302-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2851/9978155/240b3422b57b/fimmu-14-1093302-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2851/9978155/06354e1029c9/fimmu-14-1093302-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2851/9978155/d63c6a4223b6/fimmu-14-1093302-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2851/9978155/02c6797478f0/fimmu-14-1093302-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2851/9978155/92b85211e1ff/fimmu-14-1093302-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2851/9978155/b27381e5e0e8/fimmu-14-1093302-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2851/9978155/240b3422b57b/fimmu-14-1093302-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2851/9978155/06354e1029c9/fimmu-14-1093302-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2851/9978155/d63c6a4223b6/fimmu-14-1093302-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2851/9978155/02c6797478f0/fimmu-14-1093302-g006.jpg

相似文献

1
Donor derived hematopoietic stem cell niche transplantation facilitates mixed chimerism mediated donor specific tolerance.供者来源造血干细胞龛移植促进嵌合状态介导的供者特异性免疫耐受。
Front Immunol. 2023 Feb 16;14:1093302. doi: 10.3389/fimmu.2023.1093302. eCollection 2023.
2
A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance.大规模供者来源的骨髓和间充质干细胞库促进免疫调节和移植耐受。
Front Immunol. 2021 Feb 26;12:622604. doi: 10.3389/fimmu.2021.622604. eCollection 2021.
3
Donor Recipient Chimeric Cells Induce Chimerism and Extend Survival of Vascularized Composite Allografts.供者受者嵌合细胞诱导嵌合体并延长血管化复合同种异体移植物的存活。
Arch Immunol Ther Exp (Warsz). 2021 May 10;69(1):13. doi: 10.1007/s00005-021-00614-9.
4
Facilitating cells as a venue to establish mixed chimerism and tolerance.促进细胞作为建立混合嵌合体和耐受性的场所。
Pediatr Transplant. 2003 Oct;7(5):348-57. doi: 10.1034/j.1399-3046.2003.00100.x.
5
Tolerance of a Vascularized Composite Allograft Achieved in MHC Class-I-mismatch Swine Mixed Chimerism.在 MHC Ⅰ类错配猪混合嵌合体中实现血管化复合移植物的耐受。
Front Immunol. 2022 May 10;13:829406. doi: 10.3389/fimmu.2022.829406. eCollection 2022.
6
Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.联合调节性 T 细胞和带血管化骨髓移植可产生混合嵌合体,并在不进行细胞消减预处理的情况下诱导对带血管化复合异体移植物的供体特异性耐受。
J Surg Res. 2012 Dec;178(2):974-81. doi: 10.1016/j.jss.2012.06.061. Epub 2012 Jul 11.
7
A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.一种非致死性预处理方法,用于跨越主要、次要和造血组织相容性屏障实现持久的多谱系混合嵌合和耐受。
J Immunol. 1995 Nov 1;155(9):4179-88.
8
A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.一种临床可行的方法,可诱导先前接受过肾或血管化复合组织同种异体移植的受者产生延迟性耐受。
Transplantation. 2012 Oct 15;94(7):671-8. doi: 10.1097/TP.0b013e318264fbc1.
9
Simultaneous transplantation of hematopoietic stem cells and a vascularized composite allograft leads to tolerance.造血干细胞与带血管复合异体移植同时进行可导致免疫耐受。
Transplantation. 2014 Jul 27;98(2):131-8. doi: 10.1097/TP.0000000000000204.
10
Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.调节性T细胞与血管化骨髓移植联合治疗可产生混合嵌合体,并在无细胞减灭预处理的情况下诱导对血管化复合异体移植物的供体特异性耐受。
Chimerism. 2013 Jan-Mar;4(1):20-2. doi: 10.4161/chim.23349.

引用本文的文献

1
The current state of tolerance induction in vascularized composite allotransplantation.血管化复合组织同种异体移植中诱导耐受的现状。
Curr Opin Organ Transplant. 2024 Dec 1;29(6):368-375. doi: 10.1097/MOT.0000000000001176. Epub 2024 Sep 20.
2
Efficacy of Engraftment and Safety of Human Umbilical Di-Chimeric Cell (HUDC) Therapy after Systemic Intraosseous Administration in an Experimental Model.在实验模型中经全身骨内给药后人类脐双嵌合细胞(HUDC)疗法的植入效果及安全性
Biomedicines. 2024 May 11;12(5):1064. doi: 10.3390/biomedicines12051064.

本文引用的文献

1
B7-CD28 co-stimulation modulates central tolerance via thymic clonal deletion and Treg generation through distinct mechanisms.B7-CD28 共刺激通过胸腺克隆删除和 Treg 生成通过不同的机制调节中枢耐受。
Nat Commun. 2020 Dec 8;11(1):6264. doi: 10.1038/s41467-020-20070-x.
2
Treg-inducing microparticles promote donor-specific tolerance in experimental vascularized composite allotransplantation.Treg 诱导微粒在实验性血管化复合组织同种异体移植中促进供体特异性耐受。
Proc Natl Acad Sci U S A. 2019 Dec 17;116(51):25784-25789. doi: 10.1073/pnas.1910701116. Epub 2019 Dec 2.
3
The intragraft vascularized bone marrow component plays a critical role in tolerance induction after reconstructive transplantation.
移植物内血管化骨髓成分在重建移植后诱导耐受中起着关键作用。
Cell Mol Immunol. 2021 Feb;18(2):363-373. doi: 10.1038/s41423-019-0325-y. Epub 2019 Nov 21.
4
The landscape of vascularized composite allograft donation in the United States.美国血管化复合组织同种异体移植捐献的现状。
Curr Opin Organ Transplant. 2019 Dec;24(6):699-704. doi: 10.1097/MOT.0000000000000703.
5
A Lifesaving View of Vascularized Composite Allotransplantation: Patient Experience of Social Death Before and After Face, Hand, and Larynx Transplant.血管化复合组织异体移植的救命视角:面部、手部和喉部移植前后患者的社会死亡体验
J Patient Exp. 2018 Jun;5(2):92-100. doi: 10.1177/2374373517730556. Epub 2017 Oct 6.
6
Murine Full-thickness Skin Transplantation.小鼠全层皮肤移植
J Vis Exp. 2017 Jan 2(119):55105. doi: 10.3791/55105.
7
Orthotopic Hind Limb Transplantation in the Mouse.小鼠原位后肢移植
J Vis Exp. 2016 Feb 12(108):53483. doi: 10.3791/53483.
8
The hematopoietic stem cell niche in homeostasis and disease.稳态与疾病中的造血干细胞微环境
Blood. 2015 Nov 26;126(22):2443-51. doi: 10.1182/blood-2015-07-533588. Epub 2015 Oct 14.
9
Update on CD40 and CD154 blockade in transplant models.移植模型中CD40和CD154阻断的最新进展。
Immunotherapy. 2015;7(8):899-911. doi: 10.2217/IMT.15.54. Epub 2015 Aug 13.
10
Isolation and transplantation of different aged murine thymic grafts.不同年龄小鼠胸腺移植物的分离与移植
J Vis Exp. 2015 May 13(99):e52709. doi: 10.3791/52709.